RYTEZEP

EUIPO EUIPO 2020 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark RYTEZEP was filed as Word mark on 08/21/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 02/27/2021. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 018294281
Application date August 21, 2020
Publication date November 19, 2020
Entry date February 27, 2021
Expiration date August 21, 2030

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations namely, pharmaceutical preparations for the treatment, diagnosis and/or prevention of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain; pharmaceutical preparations

Trademark history

Date Document number Area Entry
November 24, 2020 Change Representative, Registered

ID: 11018294281